SL-Link

SL-Link is a South Korean medical technology company that develops innovative drug delivery systems for advanced biopharmaceuticals. As a subsidiary of SL Bigen, the company's flagship product is the SL-Link needle-free injector, a device specifically engineered to optimize the administration of DNA-based vaccines and gene therapies. This technology aims to increase the permeability of cell membranes through high-pressure micro-jets, thereby enhancing the cellular uptake of genetic material compared to traditional needle injections. SL-Link's delivery platform is currently integrated into several high-profile clinical trials, including immunotherapy programs for cervical cancer and various infectious diseases, in collaboration with partners like Genexine.